Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Sergio Hyland seemed like the perfect advocate. Calling himself a “fierce, relentless, implacable abolitionist,” determined to end incarceration in the United States, Hyland had spent more than two ...

It’s not hard to see why the choreographer felt an affinity with this writer. An iconoclast and innovator, she was fascinated by the possibilities of simultaneous timelines and fragmented time, by ...

Sir Wayne McGregor is a titan of the dance world - and a divisive one. For some he's the next Messiah, for others, the Emperor's new clothes. Normally I'm veering towards the latter, but his 2015 ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

How must databases adapt to generative AI, and how should databases be integrated with large language models (LLMs)? These are questions that Sailesh Krishnamurthy has grappled with for several years ...

New Year's Day commemorates the passing of time and the start of a new chapter, so it is fitting that the same day also presents an opportunity to breathe new life into thousands of creative works ...

Sarina Trangle started as a corporate news reporter in October 2024. She previously spent four years on the business desk at Newsday, covering the health industry, commercial real estate and cannabis.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...